Dana-Farber/Brigham and Women’s Cancer Center (Boston). Named a Blue Distinction Center for Complex & Rare Cancers in 2008, the Dana-Farber Brigham and Women’s Cancer Center is also designated a Comprehensive Cancer Center by the National Cancer Institute. In 2009, the center’s stem cell transplant program was one of only three nationwide to consistently outperform the expected one-year survival rate for unrelated donor stem cell treatments, according to the Center for International Blood & Marrow Transplant Research. U.S. News & World Report ranked Brigham and Women’s as among the best in the country for cancer care for 2015-16.
 |
 |
 |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
